BioCorRx (BICX) Inventory (2025 - 2026)

BioCorRx's (BICX) quarterly Inventory came in at $143425.0 in Q1 2026, up 7.36% year-on-year from $133597.0 in Q1 2025, and little changed quarter-over-quarter from $143425.0 in Q4 2025.

BioCorRx (BICX) Inventory (2025 - 2026) Analysis & Trends

BioCorRx has disclosed Inventory across 2 years of filings, most recently posting $143425.0 for Q1 2026.

  • Inventory for Q1 2026 came in at $143425.0, up 7.36% year-over-year; the trailing twelve-month figure through Mar 2026 was $143425.0 (up 7.36% YoY), and the FY2025 annual result was $143425.0, changed N/A from the prior year.
  • Inventory came in at $143425.0 for Q1 2026 at BioCorRx, roughly flat from $143425.0 in the prior quarter.
  • In the past five years, Inventory ranged from a high of $155367.0 in Q3 2025 to a low of $133597.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inventory (Qtr)
1 HCA Healthcare 83.85 Bn 86.23 Bn 16.26 Bn 1.68 Bn
2 Tenet Healthcare 14.98 Bn 14.15 Bn 4.41 Bn 343.00 Mn
3 Davita 13.99 Bn 14.84 Bn 1.07 Bn 141.61 Mn
4 Encompass Health 9.72 Bn 10.34 Bn 1.34 Bn -
5 Ensign 8.90 Bn 8.31 Bn 293.37 Mn -
6 Universal Health Services 8.59 Bn 8.55 Bn 3.21 Bn 229.42 Mn
7 Fresenius Medical Care AG 7.67 Bn 5.29 Bn -4.26 Bn 2.49 Bn
8 Chemed 5.97 Bn 5.96 Bn 215.76 Mn 7.21 Mn
9 Pacs 5.74 Bn 5.50 Bn 345.96 Mn -
10 BioCorRx - - 189,355.00 143,425.00

Historic Data

Download Data
DateValue
Mar 31, 2026 143,425.00
Dec 31, 2025 143,425.00
Sep 30, 2025 155,367.00
Jun 30, 2025 133,597.00
Mar 31, 2025 133,597.00